Prevalence and Determinants of Viral Suppression in Young People Living with HIV on Antiretroviral Therapy in Southern Africa: A Cross-Sectional Analysis of HIV Survey Data of 2020 and 2021.

Young People Living with HIV (YPLHIV, 15–24 years) are an important demographic of Persons Living with HIV (PLHIV) globally and in Southern Africa. However, YPLHIV experience poor outcomes across the HIV diagnostic and treatment cascade due to multiple factors. We estimated the prevalence and determ...

Descripción completa

Detalles Bibliográficos
Publicado en:AIDS & Behavior Vol. 29; no. 6; pp. 1962 - 1973
Autores principales: Msosa, Takondwa Charles, Kabaghe, Alinune, Twabi, Hussein Hassan, Mpinganjira, Samuel, Mzumara, Wongani, Sumari-De Boer, Marion, Aarnoutse, Rob, Wit, Tobias Rinke De, Chipungu, Geoffrey, Ngowi, Kennedy, Kalata, Newton, Mukoka, Madalo, Msefula, Chisomo, Swai, Iraseni, Zimba, Boston, Semphere, Robina, Makhumba, Glory, Nliwasa, Marriott
Formato: research tables/charts Journal Article
Publicado: Springer Nature Jun2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=185134584&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 185134584
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10907165
        G1T
      jtl: AIDS & Behavior
      issn: 10907165
      maglogo: N
    pubinfo:
      dt: Jun2025
      vid: 29
      iid: 6
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        185134584
        183404703
        185134584
        185134584
        10.1007/s10461-025-04662-6
        185134584
      ppf: 1962
      ppct: 11
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Prevalence and Determinants of Viral Suppression in Young People Living with HIV on Antiretroviral Therapy in Southern Africa: A Cross-Sectional Analysis of HIV Survey Data of 2020 and 2021.
      aug:
        au:
          Msosa, Takondwa Charles
          Kabaghe, Alinune
          Twabi, Hussein Hassan
          Mpinganjira, Samuel
          Mzumara, Wongani
          Sumari-De Boer, Marion
          Aarnoutse, Rob
          Wit, Tobias Rinke De
          Chipungu, Geoffrey
          Ngowi, Kennedy
          Kalata, Newton
          Mukoka, Madalo
          Msefula, Chisomo
          Swai, Iraseni
          Zimba, Boston
          Semphere, Robina
          Makhumba, Glory
          Nliwasa, Marriott
        affil: https://ror.org/04dkp9463 Amsterdam UMC, Department of Global Health, Location University of Amsterdam, Amsterdam, The Netherlands
      sug:
        subj:
          HIV Infections Epidemiology
          HIV Infections Prevention and Control
          HIV Infections Prevention and Control
          Anti-Retroviral Agents Therapeutic Use
          AIDS Patients
          Treatment Outcomes
          Viral Load
          Funding Source
          South Africa
          Human
          Male
          Female
          Adolescence
          Adult
          Middle Age
          Aged
          Aged, 80 and Over
          Cross Sectional Studies
          Confidence Intervals
          Descriptive Statistics
          Bivariate Statistics
          Multivariate Statistics
          Malawi
          Mozambique
          Zimbabwe
          Lesotho
          Adolescent: 13-18 years
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Aged: 65+ years
          Aged, 80 & over
          Male
          Female
      ab: Young People Living with HIV (YPLHIV, 15–24 years) are an important demographic of Persons Living with HIV (PLHIV) globally and in Southern Africa. However, YPLHIV experience poor outcomes across the HIV diagnostic and treatment cascade due to multiple factors. We estimated the prevalence and determinants of HIV viral suppression in YPLHIV on antiretroviral therapy (ART) in selected Southern African countries. We used publicly available data from Malawi, Zimbabwe, Mozambique, Lesotho, and Eswatini collected during the Population-based HIV Impact Assessments (PHIAs) of 2020 to 2021. Weighted proportions, and 95% confidence intervals (CI) were computed to estimate the prevalence of viral suppression (< 1000c/ml) and bivariate and multivariate analyses were conducted to identify determinants of viral suppression. A total of 855 records of YPLHIV on ART were included in the analysis. The prevalence of viral suppression in YPLHIV on ART was 82.4% (95% CI: 76.7, 86.9). Residing in Mozambique and duration on ART were inversely associated with viral suppression; adjusted odds ratios (AORs) of 0.37 (95% CI: 0.14, 0.95), and 0.87 (95% CI: 0.80, 0.94), respectively. A negative result in the depression screen, being married/cohabitating, and ever switching an ART regimen were positively associated with viral suppression: AORs of 5.78 (95% CI: 2.21, 15.11), 3.72 (95% CI: 1.44, 9.63), and 3.44 (95% CI: 1.69, 7), respectively. YPLHIV had suboptimal viral suppression lower than the UNAIDS 95% targets and may benefit from further research and tailored interventions addressing modifiable factors associated with viral suppression such as depression.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N